0.400
0.01 (2.56%)
| Previous Close | 0.390 |
| Open | 0.385 |
| Volume | 387,000 |
| Avg. Volume (3M) | 238,185 |
| Market Cap | 149,564,016 |
| Price / Earnings (TTM) | 20.00 |
| Price / Earnings (Forward) | 19.01 |
| Price / Sales | 2.78 |
| Price / Book | 1.83 |
| 52 Weeks Range |
| Profit Margin | 16.97% |
| Operating Margin (TTM) | 17.53% |
| Diluted EPS (TTM) | 0.020 |
| Quarterly Revenue Growth (YOY) | -0.40% |
| Quarterly Earnings Growth (YOY) | 20.30% |
| Total Debt/Equity (MRQ) | 0.50% |
| Current Ratio (MRQ) | 10.68 |
| Operating Cash Flow (TTM) | 10.96 M |
| Levered Free Cash Flow (TTM) | -1.68 M |
| Return on Assets (TTM) | 7.22% |
| Return on Equity (TTM) | 11.85% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (MY) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Bearish | |
| Stock | UMC | Mixed | Bearish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 0.5 |
| Average | 0.33 |
|
Umedic Group Bhd is principally involved in the marketing and distribution of various branded medical devices and consumables as well as the provision of after-sales service for all products. The company is also involved in developing, manufacturing, and marketing of medical consumables. It has two reportable segments: marketing and distribution, which includes marketing and distribution of medical devices and the provision of after-sales service; the manufacturing segment includes developing, manufacturing, and marketing of medical devices. The company generates the majority of its revenue from the marketing and distribution segment. The company has customers in Asia Pacific, Americas, Europe, Middle East, Africa, and Oceania geographically. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Growth |
| % Held by Insiders | 73.21% |
| % Held by Institutions | 5.16% |
| 52 Weeks Range | ||
| Median | 0.450 (12.50%) | |
| Total | 1 Buy | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| PHILLIP CAPITAL | 09 Sep 2025 | 0.450 (12.50%) | Buy | 0.380 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 24 Jul 2025 | Announcement | Changes in Director's Interest (Section 219 of CA 2016) - DATO NG CHAI ENG |
| 24 Jul 2025 | Announcement | DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period |
| 24 Jul 2025 | Announcement | Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DATO NG CHAI ENG |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |